首页 > 最新文献

Interventional Medicine and Applied Science最新文献

英文 中文
P wave dispersion in patients with erectile dysfunction. 勃起功能障碍患者的P波离散度。
Q2 Medicine Pub Date : 2019-06-01 DOI: 10.1556/1646.11.2019.10
Can Ramazan Öncel, Ali Akkoç

Background and aims: P wave dispersion (PWD) has been reported to be a non-invasive electrocardiographic predictor for atrial fibrillation. The aim of this study is to evaluate PWD between men with erectile dysfunction (ED) and healthy controls in order to investigate whether PWD was prolonged in patients with ED and related to severity of the disease.

Methods: This study included a total of 72 men (42 patients with ED and 30 healthy controls). Demographic data and clinical features were recorded on admission. An electrocardiographic evaluation was obtained to measure PWD values for both patients and controls.

Results: Maximum P wave duration was 108.5 ± 4.7 and 108.3 ± 4.3 in ED group and control group, respectively (p = 0.748). Minumum P wave duration was significantly higher in the control group than in the ED group. PWD was 48.1 ± 5.9 in the ED group. As a result, PWD was prolonged in patients with ED (48.1 ± 5.9 vs. 38.0 ± 3.9, p < 0.05). A significant negative correlation was observed between IIEF score and PWD values (p < 0.05, r = -0.662).

Conclusions: Patients with ED exhibited prolonged PWD values compared with normal controls. In addition, PWD was found to be associated with severity of the disease.

背景和目的:P波离散度(PWD)已被报道为心房颤动的无创心电图预测指标。本研究的目的是评估男性勃起功能障碍(ED)和健康对照之间的PWD,以探讨ED患者的PWD是否延长以及与疾病严重程度的关系。方法:本研究共纳入72名男性(42名ED患者和30名健康对照)。入院时记录人口学资料和临床特征。通过心电图评估来测量患者和对照组的PWD值。结果:ED组和对照组最大P波持续时间分别为108.5±4.7和108.3±4.3 (P = 0.748)。对照组的最短P波持续时间明显高于ED组。ED组PWD为48.1±5.9。结果,ED患者的PWD延长(48.1±5.9比38.0±3.9,p pr = -0.662)。结论:与正常对照相比,ED患者的PWD值延长。此外,发现PWD与疾病的严重程度有关。
{"title":"P wave dispersion in patients with erectile dysfunction.","authors":"Can Ramazan Öncel,&nbsp;Ali Akkoç","doi":"10.1556/1646.11.2019.10","DOIUrl":"https://doi.org/10.1556/1646.11.2019.10","url":null,"abstract":"<p><strong>Background and aims: </strong>P wave dispersion (PWD) has been reported to be a non-invasive electrocardiographic predictor for atrial fibrillation. The aim of this study is to evaluate PWD between men with erectile dysfunction (ED) and healthy controls in order to investigate whether PWD was prolonged in patients with ED and related to severity of the disease.</p><p><strong>Methods: </strong>This study included a total of 72 men (42 patients with ED and 30 healthy controls). Demographic data and clinical features were recorded on admission. An electrocardiographic evaluation was obtained to measure PWD values for both patients and controls.</p><p><strong>Results: </strong>Maximum P wave duration was 108.5 ± 4.7 and 108.3 ± 4.3 in ED group and control group, respectively (<i>p</i> = 0.748). Minumum P wave duration was significantly higher in the control group than in the ED group. PWD was 48.1 ± 5.9 in the ED group. As a result, PWD was prolonged in patients with ED (48.1 ± 5.9 vs. 38.0 ± 3.9, <i>p</i> < 0.05). A significant negative correlation was observed between IIEF score and PWD values (<i>p</i> < 0.05, <i>r</i> = -0.662).</p><p><strong>Conclusions: </strong>Patients with ED exhibited prolonged PWD values compared with normal controls. In addition, PWD was found to be associated with severity of the disease.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":"11 2","pages":"101-105"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.11.2019.10","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Daikenchuto improved perioperative nutritional status of the patients with colorectal cancer: A prospective open-labeled randomized exploratory study. Daikenchuto改善结直肠癌患者围手术期营养状况:一项前瞻性开放标记随机探索性研究。
Q2 Medicine Pub Date : 2019-06-01 DOI: 10.1556/1646.11.2019.13
Fumihiko Fujita, Yasuhiro Torashima, Yusuke Inoue, Shinichiro Ito, Kazuma Kobayashi, Kengo Kanetaka, Mitsuhisa Takatsuki, Susumu Eguchi

Background and aims: The aim of this study is to exploratively evaluate the effect of Tsumura Daikenchuto Extract Granules (DKT, TJ-100) on abdominal symptoms, body weight, and nutritional function following colorectal cancer surgery.

Methods: The subjects included 20 patients for curative resection of colorectal cancer. A TJ-100 administration group (n = 10) and non-administration group (n = 10) were randomized and compared. In the administration group, TJ-100 was administered from 2 days prior to surgery up to 12 weeks following surgery. The endpoints included body weight gain, Gastrointestinal Symptom Rating Scale (GSRS), and blood biochemical factors. For the purpose of observing safety, drug adverse events were evaluated including liver function tests.

Results: Excluding one patient, we compared 9 cases in the administration group and 10 cases in the non-administration group. No obvious adverse events were observed in any of the cases. In the comparison of body weight gain, the TJ-100 administration group showed significantly higher values at 2, 4, and 12 weeks following the surgery. There was a tendency for lower stable GSRS scores in the administration group overall, with no statistically significant difference.

Conclusion: It is suggested that TJ-100 can be safely administered in the perioperative period for cases undergoing colorectal cancer surgery, potentially preventing weight loss during the early postoperative period.

背景与目的:本研究旨在探讨Tsumura Daikenchuto提取物颗粒(DKT, TJ-100)对结直肠癌术后腹部症状、体重和营养功能的影响。方法:选取20例结肠直肠癌根治性切除术患者作为研究对象。随机选取TJ-100给药组(n = 10)和非给药组(n = 10)进行比较。给药组从术前2天至术后12周给予TJ-100。终点包括体重增加、胃肠道症状评定量表(GSRS)和血液生化因子。为了观察安全性,对药物不良事件进行评估,包括肝功能检查。结果:除1例外,给药组9例,非给药组10例。所有病例均未见明显不良反应。在体重增加的比较中,TJ-100给药组在术后2周、4周和12周的体重增加明显更高。总体而言,给药组的稳定GSRS评分有降低的趋势,但无统计学差异。结论:TJ-100可安全用于结直肠癌手术围手术期,可预防术后早期体重下降。
{"title":"Daikenchuto improved perioperative nutritional status of the patients with colorectal cancer: A prospective open-labeled randomized exploratory study.","authors":"Fumihiko Fujita,&nbsp;Yasuhiro Torashima,&nbsp;Yusuke Inoue,&nbsp;Shinichiro Ito,&nbsp;Kazuma Kobayashi,&nbsp;Kengo Kanetaka,&nbsp;Mitsuhisa Takatsuki,&nbsp;Susumu Eguchi","doi":"10.1556/1646.11.2019.13","DOIUrl":"https://doi.org/10.1556/1646.11.2019.13","url":null,"abstract":"<p><strong>Background and aims: </strong>The aim of this study is to exploratively evaluate the effect of Tsumura Daikenchuto Extract Granules (DKT, TJ-100) on abdominal symptoms, body weight, and nutritional function following colorectal cancer surgery.</p><p><strong>Methods: </strong>The subjects included 20 patients for curative resection of colorectal cancer. A TJ-100 administration group (<i>n</i> = 10) and non-administration group (<i>n</i> = 10) were randomized and compared. In the administration group, TJ-100 was administered from 2 days prior to surgery up to 12 weeks following surgery. The endpoints included body weight gain, Gastrointestinal Symptom Rating Scale (GSRS), and blood biochemical factors. For the purpose of observing safety, drug adverse events were evaluated including liver function tests.</p><p><strong>Results: </strong>Excluding one patient, we compared 9 cases in the administration group and 10 cases in the non-administration group. No obvious adverse events were observed in any of the cases. In the comparison of body weight gain, the TJ-100 administration group showed significantly higher values at 2, 4, and 12 weeks following the surgery. There was a tendency for lower stable GSRS scores in the administration group overall, with no statistically significant difference.</p><p><strong>Conclusion: </strong>It is suggested that TJ-100 can be safely administered in the perioperative period for cases undergoing colorectal cancer surgery, potentially preventing weight loss during the early postoperative period.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":"11 2","pages":"84-88"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.11.2019.13","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions. 经皮治疗慢性全闭塞造影剂肾病的评价。
Q2 Medicine Pub Date : 2019-06-01 DOI: 10.1556/1646.11.2019.15
Erdal Aktürk, Lütfü Aşkın, Hakan Taşolar, Ertuğrul Kurtoğlu, Serdar Türkmen, Okan Tanrıverdi, Kader Eliz Uzel

Background: Contrast-induced nephropathy (CIN) is a leading cause of morbidity and mortality in patients undergoing percutaneous coronary intervention (PCI). Chronic total occlusions (CTO) are frequently observed among patients undergoing coronary angiography.

Methods: A total of 128 CTO patients were included. Mehran score, lesion characteristics, interventional procedure, serological specimens and devices were recorded. The first group was administered with 1 ml · kg-1 · h-1 saline (0.9% NaCl) infusion that started 12 h before the procedure and continued 12 h post procedure as recommended by the guidelines. The second group was administered with saline infusion of 12 ml · kg-1 · h-1 only during CTO-PCI procedure, which is called as intensive infusion.

Results: CIN development was similar in two groups (four patients in standard hydration group and five patients in intensive hydration group). The amount of saline was significantly higher in the standard group (1,767 ± 192.2 vs. 1,043.6 ± 375; p < 0.001). Patients with higher creatinine levels prior to PCI had a higher rate of CIN development after procedure. Interestingly, age, left ventricular ejection fraction, and diabetes mellitus independently predicted CIN.

Conclusion: Intensive hydration administration appears to be an effective and cost-effective method in CTO-PCI patients, especially in patients without left ventricular function failure.

背景:造影剂肾病(CIN)是经皮冠状动脉介入治疗(PCI)患者发病和死亡的主要原因。慢性全闭塞(CTO)在冠状动脉造影患者中经常被观察到。方法:共纳入128例CTO患者。记录Mehran评分、病变特征、介入方式、血清学标本及器械。第一组按指南建议在手术前12小时开始输注1 ml·kg-1·h-1生理盐水(0.9% NaCl),并在术后12小时继续输注。第二组仅在CTO-PCI术中灌注12 ml·kg-1·h-1生理盐水,称为强化输注。结果:两组(标准水合组4例,强化水合组5例)CIN发展相似。标准组生理盐水量明显高于对照组(1767±192.2 vs 1043.6±375;结论:对于CTO-PCI患者,特别是无左心功能衰竭的患者,强化水化治疗似乎是一种有效且具有成本效益的方法。
{"title":"Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions.","authors":"Erdal Aktürk,&nbsp;Lütfü Aşkın,&nbsp;Hakan Taşolar,&nbsp;Ertuğrul Kurtoğlu,&nbsp;Serdar Türkmen,&nbsp;Okan Tanrıverdi,&nbsp;Kader Eliz Uzel","doi":"10.1556/1646.11.2019.15","DOIUrl":"https://doi.org/10.1556/1646.11.2019.15","url":null,"abstract":"<p><strong>Background: </strong>Contrast-induced nephropathy (CIN) is a leading cause of morbidity and mortality in patients undergoing percutaneous coronary intervention (PCI). Chronic total occlusions (CTO) are frequently observed among patients undergoing coronary angiography.</p><p><strong>Methods: </strong>A total of 128 CTO patients were included. Mehran score, lesion characteristics, interventional procedure, serological specimens and devices were recorded. The first group was administered with 1 ml · kg<sup>-1</sup> · h<sup>-1</sup> saline (0.9% NaCl) infusion that started 12 h before the procedure and continued 12 h post procedure as recommended by the guidelines. The second group was administered with saline infusion of 12 ml · kg<sup>-1</sup> · h<sup>-1</sup> only during CTO-PCI procedure, which is called as intensive infusion.</p><p><strong>Results: </strong>CIN development was similar in two groups (four patients in standard hydration group and five patients in intensive hydration group). The amount of saline was significantly higher in the standard group (1,767 ± 192.2 vs. 1,043.6 ± 375; <i>p</i> < 0.001). Patients with higher creatinine levels prior to PCI had a higher rate of CIN development after procedure. Interestingly, age, left ventricular ejection fraction, and diabetes mellitus independently predicted CIN.</p><p><strong>Conclusion: </strong>Intensive hydration administration appears to be an effective and cost-effective method in CTO-PCI patients, especially in patients without left ventricular function failure.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":"11 2","pages":"95-100"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.11.2019.15","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Evaluation of homocystein and asymmetric dimethyl arginine levels in patients with coronary slow flow phenomenon. 冠状动脉慢血流患者同型半胱氨酸和非对称二甲基精氨酸水平的评价。
Q2 Medicine Pub Date : 2019-06-01 DOI: 10.1556/1646.11.2019.07
Erkan Demirci, Oğuzhan Çelik, Macit Kalçık, Lütfü Bekar, Mucahit Yetim, Tolga Doğan

Background: Previous studies have demonstrated that homocysteine and asymmetric dimethyl arginine (ADMA) levels were strongly associated with cardiovascular diseases including coronary artery disease. The aim of this study was to investigate the role of plasma homocysteine and ADMA levels in the pathogenesis of coronary slow flow (CSF) phenomenon.

Methods: Twenty-three patients with CSF and 25 controls with normal coronary flow were included in this study. The quantitative measurement of coronary blood flow was performed using the thrombolysis in myocardial infarction frame count method. Plasma homocysteine and ADMA levels were determined using enzymatic assays from venous blood samples.

Results: The patients with CSF had significantly higher plasma homocysteine levels than controls (16.2 ± 7.6 vs. 12.2 ± 2.2 μM/L; p = 0.023). The uric acid levels were significantly higher in CSF group than controls (5.4 ± 1.1 vs. 4.6 ± 0.9 mg/dl; p = 0.011). Plasma ADMA levels were also higher in the CSF group; however, this was not statistically significant (0.6 ± 0.1 vs. 0.5 ± 0.2 μM/L; p = 0.475).

Conclusions: Increased homocysteine and uric acid levels may play an important role in the pathogenesis of CSF. Further large scale studies are required to determine the relationship between ADMA levels and CSF.

背景:以往的研究表明,同型半胱氨酸和不对称二甲基精氨酸(ADMA)水平与包括冠状动脉疾病在内的心血管疾病密切相关。本研究旨在探讨血浆同型半胱氨酸和ADMA水平在冠状动脉慢流(CSF)发病机制中的作用。方法:23例脑脊液患者和25例冠状动脉血流正常的对照组。采用心肌梗死溶栓框架计数法定量测定冠状动脉血流量。血浆同型半胱氨酸和ADMA水平用静脉血样品的酶法测定。结果:脑脊液患者血浆同型半胱氨酸水平显著高于对照组(16.2±7.6 vs 12.2±2.2 μM/L;p = 0.023)。脑脊液组尿酸水平显著高于对照组(5.4±1.1 vs. 4.6±0.9 mg/dl;p = 0.011)。脑脊液组血浆ADMA水平也较高;但差异无统计学意义(0.6±0.1 vs. 0.5±0.2 μM/L;p = 0.475)。结论:同型半胱氨酸和尿酸水平升高可能在脑脊液的发病机制中起重要作用。需要进一步的大规模研究来确定ADMA水平与CSF之间的关系。
{"title":"Evaluation of homocystein and asymmetric dimethyl arginine levels in patients with coronary slow flow phenomenon.","authors":"Erkan Demirci,&nbsp;Oğuzhan Çelik,&nbsp;Macit Kalçık,&nbsp;Lütfü Bekar,&nbsp;Mucahit Yetim,&nbsp;Tolga Doğan","doi":"10.1556/1646.11.2019.07","DOIUrl":"https://doi.org/10.1556/1646.11.2019.07","url":null,"abstract":"<p><strong>Background: </strong>Previous studies have demonstrated that homocysteine and asymmetric dimethyl arginine (ADMA) levels were strongly associated with cardiovascular diseases including coronary artery disease. The aim of this study was to investigate the role of plasma homocysteine and ADMA levels in the pathogenesis of coronary slow flow (CSF) phenomenon.</p><p><strong>Methods: </strong>Twenty-three patients with CSF and 25 controls with normal coronary flow were included in this study. The quantitative measurement of coronary blood flow was performed using the thrombolysis in myocardial infarction frame count method. Plasma homocysteine and ADMA levels were determined using enzymatic assays from venous blood samples.</p><p><strong>Results: </strong>The patients with CSF had significantly higher plasma homocysteine levels than controls (16.2 ± 7.6 vs. 12.2 ± 2.2 μM/L; <i>p</i> = 0.023). The uric acid levels were significantly higher in CSF group than controls (5.4 ± 1.1 vs. 4.6 ± 0.9 mg/dl; <i>p</i> = 0.011). Plasma ADMA levels were also higher in the CSF group; however, this was not statistically significant (0.6 ± 0.1 vs. 0.5 ± 0.2 μM/L; <i>p</i> = 0.475).</p><p><strong>Conclusions: </strong>Increased homocysteine and uric acid levels may play an important role in the pathogenesis of CSF. Further large scale studies are required to determine the relationship between ADMA levels and CSF.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":"11 2","pages":"89-94"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.11.2019.07","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Echocardiographic measurement of epicardial adipose tissue thickness in patients with microvascular angina. 微血管性心绞痛患者心外膜脂肪组织厚度的超声心动图测量。
Q2 Medicine Pub Date : 2019-06-01 DOI: 10.1556/1646.11.2019.12
Macit Kalçık, Mahmut Yesin, Ahmet Güner, Emrah Bayam, Mucahit Yetim, Tolga Doğan, Lütfü Bekar, Oğuzhan Çelik, Yusuf Karavelioğlu

Introduction: Impaired coronary microcirculation, inflammation, and endothelial dysfunction were reported etiological factors for microvascular angina (MVA). Recently, increased epicardial adipose tissue (EAT) thickness has been associated with hypertension, metabolic syndrome, and coronary artery disease in general population. In this study, we aimed to evaluate the EAT thickness in patients with MVA.

Methods: This study enrolled 200 patients (83 males; mean age: 55.4 ± 8.2 years) who have been diagnosed with MVA and 200 controls (89 males; mean age: 54.4 ± 8.5 years). All patients underwent transthoracic echocardiography, and EAT thickness was measured from a parasternal long-axis view as the hypoechoic space on the right ventricular free wall.

Results: The mean EAT thickness was significantly higher in MVA patients than the controls (5.5 ± 1.1 vs. 4.9 ± 0.7 mm; p < 0.001). Multiple logistic regression analysis showed that increased EAT thickness was an independent predictor of MVA (OR = 1.183, 95% CI = 1.063-1.489; p = 0.023). In receiver operating characteristic curve analyses, EAT thickness above 5.3 mm predicted MVA with a sentivity of 68% and a specificity of 63% (AUC = 0.711, 95% CI = 0.659-0.762; p < 0.001).

Conclusions: The EAT thickness was observed significantly higher in MVA patients as compared to controls. Increased EAT thickness may be associated with mechanisms that play a major role in the pathogenesis of MVA.

导语:冠状动脉微循环受损、炎症和内皮功能障碍是微血管心绞痛(MVA)的病因。最近,在一般人群中,心外膜脂肪组织(EAT)厚度增加与高血压、代谢综合征和冠状动脉疾病有关。在本研究中,我们旨在评估MVA患者的EAT厚度。方法:本研究纳入200例患者(男性83例;平均年龄:55.4±8.2岁),对照组200例(男性89例;平均年龄:54.4±8.5岁)。所有患者都进行了经胸超声心动图检查,并从胸骨旁长轴视图作为右心室游离壁的低回声空间测量EAT厚度。结果:MVA患者的平均EAT厚度显著高于对照组(5.5±1.1 vs. 4.9±0.7 mm;p = 0.023)。在受试者工作特征曲线分析中,EAT厚度大于5.3 mm预测MVA的敏感性为68%,特异性为63% (AUC = 0.711, 95% CI = 0.659-0.762;结论:与对照组相比,MVA患者的EAT厚度明显增高。EAT厚度增加可能与在MVA发病机制中起主要作用的机制有关。
{"title":"Echocardiographic measurement of epicardial adipose tissue thickness in patients with microvascular angina.","authors":"Macit Kalçık,&nbsp;Mahmut Yesin,&nbsp;Ahmet Güner,&nbsp;Emrah Bayam,&nbsp;Mucahit Yetim,&nbsp;Tolga Doğan,&nbsp;Lütfü Bekar,&nbsp;Oğuzhan Çelik,&nbsp;Yusuf Karavelioğlu","doi":"10.1556/1646.11.2019.12","DOIUrl":"https://doi.org/10.1556/1646.11.2019.12","url":null,"abstract":"<p><strong>Introduction: </strong>Impaired coronary microcirculation, inflammation, and endothelial dysfunction were reported etiological factors for microvascular angina (MVA). Recently, increased epicardial adipose tissue (EAT) thickness has been associated with hypertension, metabolic syndrome, and coronary artery disease in general population. In this study, we aimed to evaluate the EAT thickness in patients with MVA.</p><p><strong>Methods: </strong>This study enrolled 200 patients (83 males; mean age: 55.4 ± 8.2 years) who have been diagnosed with MVA and 200 controls (89 males; mean age: 54.4 ± 8.5 years). All patients underwent transthoracic echocardiography, and EAT thickness was measured from a parasternal long-axis view as the hypoechoic space on the right ventricular free wall.</p><p><strong>Results: </strong>The mean EAT thickness was significantly higher in MVA patients than the controls (5.5 ± 1.1 vs. 4.9 ± 0.7 mm; <i>p</i> < 0.001). Multiple logistic regression analysis showed that increased EAT thickness was an independent predictor of MVA (OR = 1.183, 95% CI = 1.063-1.489; <i>p</i> = 0.023). In receiver operating characteristic curve analyses, EAT thickness above 5.3 mm predicted MVA with a sentivity of 68% and a specificity of 63% (AUC = 0.711, 95% CI = 0.659-0.762; <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>The EAT thickness was observed significantly higher in MVA patients as compared to controls. Increased EAT thickness may be associated with mechanisms that play a major role in the pathogenesis of MVA.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":"11 2","pages":"106-111"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.11.2019.12","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Copeptin levels in patients with coronary artery ectasia. 冠状动脉扩张患者的Copeptin水平。
Q2 Medicine Pub Date : 2019-06-01 DOI: 10.1556/1646.11.2019.08
Ozkan Yavcin, Lutfu Askin, Ozlem Seçen, Serdar Turkmen, Erdal Akturk, Okan Tanriverdi, Mustafa Necati Dagli

Background and aims: The etiology and pathophysiology of coronary artery ectasia (CAE) has not been fully elucidated. A rapid rise in plasma copeptin has been observed in cardiovascular diseases, stroke, sepsis, and shock. This increase has diagnostic and prognostic value. The aim of this study was to investigate whether copeptin has a relationship with CAE.

Methods: This observational prospective study was carried out between October 2012 and March 2013 in the cardiology catheter laboratory with the inclusion of 44 subjects with a diagnosis of CAE and 44 age- and gender-matched individuals with normal coronary arteries. Blood samples obtained from the patients were stored at -70 °C until analysis and copeptin levels in sera were measured by ELISA.

Results: This study comprised 88 study participants, among whom 44 were patients meeting ectasia criteria [mean age: 58.0 ± 11.5 years; 59% (n = 26) male], and 44 were control subjects with angiographically normal coronary anatomy [mean age: 49.2 ± 10.1 years; 30% (n = 13) male]. Copeptin levels were similar between the groups (p > 0.05). In addition, there was no correlation between copeptin levels and CAE.

Conclusion: In this study, it is examined that copeptin levels were not elevated in CAE patients.

背景与目的:冠状动脉扩张(CAE)的病因和病理生理尚未完全阐明。血浆copeptin在心血管疾病、中风、败血症和休克中迅速升高。这种增加具有诊断和预后价值。本研究的目的是探讨copeptin是否与CAE有关系。方法:这项观察性前瞻性研究于2012年10月至2013年3月在心内科导管实验室进行,包括44名诊断为CAE的受试者和44名年龄和性别匹配的冠状动脉正常个体。将患者的血样保存在-70°C以待分析,并通过ELISA测定血清中copeptin的水平。结果:本研究纳入88名研究参与者,其中44名患者符合扩张标准[平均年龄:58.0±11.5岁;59% (n = 26)为男性,44例为冠状动脉造影解剖正常的对照组[平均年龄:49.2±10.1岁;30% (n = 13)男性]。两组间Copeptin水平差异无统计学意义(p > 0.05)。此外,copeptin水平与CAE无相关性。结论:本研究检验了CAE患者copeptin水平未升高。
{"title":"Copeptin levels in patients with coronary artery ectasia.","authors":"Ozkan Yavcin,&nbsp;Lutfu Askin,&nbsp;Ozlem Seçen,&nbsp;Serdar Turkmen,&nbsp;Erdal Akturk,&nbsp;Okan Tanriverdi,&nbsp;Mustafa Necati Dagli","doi":"10.1556/1646.11.2019.08","DOIUrl":"https://doi.org/10.1556/1646.11.2019.08","url":null,"abstract":"<p><strong>Background and aims: </strong>The etiology and pathophysiology of coronary artery ectasia (CAE) has not been fully elucidated. A rapid rise in plasma copeptin has been observed in cardiovascular diseases, stroke, sepsis, and shock. This increase has diagnostic and prognostic value. The aim of this study was to investigate whether copeptin has a relationship with CAE.</p><p><strong>Methods: </strong>This observational prospective study was carried out between October 2012 and March 2013 in the cardiology catheter laboratory with the inclusion of 44 subjects with a diagnosis of CAE and 44 age- and gender-matched individuals with normal coronary arteries. Blood samples obtained from the patients were stored at -70 °C until analysis and copeptin levels in sera were measured by ELISA.</p><p><strong>Results: </strong>This study comprised 88 study participants, among whom 44 were patients meeting ectasia criteria [mean age: 58.0 ± 11.5 years; 59% (<i>n</i> = 26) male], and 44 were control subjects with angiographically normal coronary anatomy [mean age: 49.2 ± 10.1 years; 30% (<i>n</i> = 13) male]. Copeptin levels were similar between the groups (<i>p</i> > 0.05). In addition, there was no correlation between copeptin levels and CAE.</p><p><strong>Conclusion: </strong>In this study, it is examined that copeptin levels were not elevated in CAE patients.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":"11 2","pages":"112-116"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.11.2019.08","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
In situ reconstruction of an MRSA-infected paravisceral aortic pseudoaneurysm with cryopreserved aortic allograft. 低温保存同种异体主动脉移植原位重建mrsa感染的内脏旁主动脉假性动脉瘤。
Q2 Medicine Pub Date : 2019-06-01 DOI: 10.1556/1646.11.2019.11
Peter Banga, Peter Legeza, Zoltán Szeberin

Objectives: Treatment of paravisceral aortic infections poses several challenges because standard therapy with excision of all infected tissues and extraanatomic reconstruction is frequently not possible without jeopardizing visceral perfusion. In situ reconstruction with rifampin-soaked prosthetic graft or endovascular repair with stent grafts runs the risk of reinfection. We present a case of a paravisceral aortic infection, where cryopreserved allograft was used for the reconstruction of the aorta.

Methods: Medical documentation and CT angiography studies were retrospectively reviewed for a patient in a tertiary care center.

Results: A 62-year-old male patient presented with an infected pseudoaneurysm of the paravisceral aorta at the level of the celiac artery. He had previously undergone multiple orthopedic surgical interventions and developed methicillin-resistant Staphylococcus aureus infections. We successfully repaired the paravisceral pseudoaneurysm with excision of all infected tissues and in situ aortic replacement with a cryopreserved allograft.

Conclusion: In case of infected aortic pseudoaneurysm, the use of cryopreserved aortic allograft is a reliable choice for reconstruction of the aorta.

目的:治疗内脏旁主动脉感染带来了一些挑战,因为在不损害内脏灌注的情况下,切除所有感染组织和解剖外重建的标准治疗往往是不可能的。用利福平浸泡的假体原位重建或血管内支架修复存在再次感染的风险。我们提出一个病例的内脏旁主动脉感染,其中冷冻保存异体移植物用于主动脉重建。方法:回顾性分析一位三级医疗中心患者的医学文献和CT血管造影研究。结果:一名62岁男性患者在腹腔动脉水平表现为感染的内脏旁主动脉假性动脉瘤。他之前曾接受过多次骨科手术干预,并出现耐甲氧西林金黄色葡萄球菌感染。我们成功地修复了内脏旁的假性动脉瘤,切除了所有感染的组织,并用冷冻保存的同种异体移植物原位替换主动脉。结论:对于感染的主动脉假性动脉瘤,采用同种异体低温保存主动脉瓣是重建主动脉的可靠选择。
{"title":"<i>In situ</i> reconstruction of an MRSA-infected paravisceral aortic pseudoaneurysm with cryopreserved aortic allograft.","authors":"Peter Banga,&nbsp;Peter Legeza,&nbsp;Zoltán Szeberin","doi":"10.1556/1646.11.2019.11","DOIUrl":"https://doi.org/10.1556/1646.11.2019.11","url":null,"abstract":"<p><strong>Objectives: </strong>Treatment of paravisceral aortic infections poses several challenges because standard therapy with excision of all infected tissues and extraanatomic reconstruction is frequently not possible without jeopardizing visceral perfusion. <i>In situ</i> reconstruction with rifampin-soaked prosthetic graft or endovascular repair with stent grafts runs the risk of reinfection. We present a case of a paravisceral aortic infection, where cryopreserved allograft was used for the reconstruction of the aorta.</p><p><strong>Methods: </strong>Medical documentation and CT angiography studies were retrospectively reviewed for a patient in a tertiary care center.</p><p><strong>Results: </strong>A 62-year-old male patient presented with an infected pseudoaneurysm of the paravisceral aorta at the level of the celiac artery. He had previously undergone multiple orthopedic surgical interventions and developed methicillin-resistant <i>Staphylococcus aureus</i> infections. We successfully repaired the paravisceral pseudoaneurysm with excision of all infected tissues and <i>in situ</i> aortic replacement with a cryopreserved allograft.</p><p><strong>Conclusion: </strong>In case of infected aortic pseudoaneurysm, the use of cryopreserved aortic allograft is a reliable choice for reconstruction of the aorta.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":"11 2","pages":"122-124"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.11.2019.11","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Anthropometric, body composition, and somatotype characteristics of Japanese young women: Implications for normal-weight obesity syndrome and sarcopenia diagnosis criteria. 日本年轻女性的人体测量、身体组成和体型特征:对正常体重肥胖综合征和肌肉减少症诊断标准的影响
Q2 Medicine Pub Date : 2019-06-01 DOI: 10.1556/1646.11.2019.14
Tomohiro Yasuda

Aims: The purpose of this study was to examine the anthropometric, body composition, and somatotype characteristics of Japanese young women and to focus on normal-weight obesity syndrome and sarcopenia diagnosis criteria.

Methods: A total of 124 Japanese university freshmen women were measured at body mass index (BMI), percent body fat and skeletal muscle index (SMI), usual gait test, and handgrip strength. The subjects were divided into obesity (≥30% body fat; BMI: ≥25.0 kg/m2), normal-weight obesity (≥30% body fat; BMI: 18.5-24.9 kg/m2), sarcopenia (handgrip, <18 kg; gait speed: ≤0.8 m/s; SMI: <5.7 kg/m2), or presarcopenia (SMI: <5.7 kg/m2). There were no subjects below the sarcopenia diagnosis criteria in usual gait speed, but not for handgrip (0.8%) and SMI (36.3%).

Results: The prevalence of presarcopenia group (36.3%) is higher than in the normal-weight obesity (16.9%) and obesity (4.8%) groups. Anthropometry and sarcopenia diagnosis assessments were significantly higher in normal-weight obesity and standard groups compared with presarcopenia group.

Discussion: The number of young women was higher in the presarcopenia group than in the normal-weight obesity group, suggesting that the improvement of intrinsic skeletal muscle mass rather than fat mass is important for Japanese young women.

目的:本研究的目的是检查日本年轻女性的人体测量学、身体组成和体型特征,并重点研究正常体重肥胖综合征和肌肉减少症的诊断标准。方法:对124名日本大学新生进行身体质量指数(BMI)、体脂百分比和骨骼肌指数(SMI)、步态测试和握力测试。受试者分为肥胖组(体脂≥30%;BMI:≥25.0 kg/m2),正常体重肥胖(体脂≥30%;BMI: 18.5-24.9 kg/m2),肌肉减少症(握力,2),或肌少症前期(SMI: 2)。正常步速没有低于肌肉减少症诊断标准的受试者,但握力(0.8%)和SMI(36.3%)没有低于诊断标准。结果:骨质减少症组患病率(36.3%)高于正常体重肥胖组(16.9%)和肥胖组(4.8%)。体重正常肥胖组和标准肥胖组的人体测量和肌肉减少症诊断评估明显高于肌肉减少症前期组。讨论:骨质减少症组的年轻女性数量高于正常体重肥胖组,这表明对日本年轻女性来说,内在骨骼肌质量的改善比脂肪质量更重要。
{"title":"Anthropometric, body composition, and somatotype characteristics of Japanese young women: Implications for normal-weight obesity syndrome and sarcopenia diagnosis criteria.","authors":"Tomohiro Yasuda","doi":"10.1556/1646.11.2019.14","DOIUrl":"https://doi.org/10.1556/1646.11.2019.14","url":null,"abstract":"<p><strong>Aims: </strong>The purpose of this study was to examine the anthropometric, body composition, and somatotype characteristics of Japanese young women and to focus on normal-weight obesity syndrome and sarcopenia diagnosis criteria.</p><p><strong>Methods: </strong>A total of 124 Japanese university freshmen women were measured at body mass index (BMI), percent body fat and skeletal muscle index (SMI), usual gait test, and handgrip strength. The subjects were divided into obesity (≥30% body fat; BMI: ≥25.0 kg/m<sup>2</sup>), normal-weight obesity (≥30% body fat; BMI: 18.5-24.9 kg/m<sup>2</sup>), sarcopenia (handgrip, <18 kg; gait speed: ≤0.8 m/s; SMI: <5.7 kg/m<sup>2</sup>), or presarcopenia (SMI: <5.7 kg/m<sup>2</sup>). There were no subjects below the sarcopenia diagnosis criteria in usual gait speed, but not for handgrip (0.8%) and SMI (36.3%).</p><p><strong>Results: </strong>The prevalence of presarcopenia group (36.3%) is higher than in the normal-weight obesity (16.9%) and obesity (4.8%) groups. Anthropometry and sarcopenia diagnosis assessments were significantly higher in normal-weight obesity and standard groups compared with presarcopenia group.</p><p><strong>Discussion: </strong>The number of young women was higher in the presarcopenia group than in the normal-weight obesity group, suggesting that the improvement of intrinsic skeletal muscle mass rather than fat mass is important for Japanese young women.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":"11 2","pages":"117-121"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.11.2019.14","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Neuroprotection against stroke and encephalopathy after cardiac surgery. 心脏手术后对中风和脑病的神经保护。
Q2 Medicine Pub Date : 2019-03-01 DOI: 10.1556/1646.11.2019.01
Daniel G Jovin, Karl G Katlaps, Ben K Ellis, Benita Dharmaraj

Cerebral ischemia in the perioperative period is a major risk factor for stroke, encephalopathy, and cognitive decline after cardiothoracic surgery. After coronary artery bypass grafting, both stroke and encephalopathy can result in poor patient outcomes and increased mortality. Neuroprotection aims to lessen the severity and occurrence of further injury mediated by stroke and encephalopathy and to aid the recovery of conditions already present. Several pharmacological and non-pharmacological methods of neuroprotection have been investigated in experimental studies and in animal models, and, although some have shown effectiveness in protection of the central nervous system, for most, clinical research is lacking or did not show the expected results. This review summarizes the value and need for neuroprotection in the context of cardiothoracic surgery and examines the use and effectiveness of several agents and methods with an emphasis on clinical trials and clinically relevant neuroprotectants.

围手术期脑缺血是心外科术后卒中、脑病和认知能力下降的主要危险因素。冠状动脉旁路移植术后,中风和脑病都可能导致患者预后不佳和死亡率增加。神经保护旨在减轻中风和脑病介导的进一步损伤的严重程度和发生,并帮助已经存在的疾病的恢复。在实验研究和动物模型中研究了几种神经保护的药理学和非药理学方法,尽管有些方法显示出对中枢神经系统的保护效果,但大多数临床研究缺乏或没有显示出预期的结果。本文综述了在心胸外科背景下神经保护的价值和必要性,并探讨了几种药物和方法的使用和有效性,重点介绍了临床试验和临床相关的神经保护剂。
{"title":"Neuroprotection against stroke and encephalopathy after cardiac surgery.","authors":"Daniel G Jovin,&nbsp;Karl G Katlaps,&nbsp;Ben K Ellis,&nbsp;Benita Dharmaraj","doi":"10.1556/1646.11.2019.01","DOIUrl":"https://doi.org/10.1556/1646.11.2019.01","url":null,"abstract":"<p><p>Cerebral ischemia in the perioperative period is a major risk factor for stroke, encephalopathy, and cognitive decline after cardiothoracic surgery. After coronary artery bypass grafting, both stroke and encephalopathy can result in poor patient outcomes and increased mortality. Neuroprotection aims to lessen the severity and occurrence of further injury mediated by stroke and encephalopathy and to aid the recovery of conditions already present. Several pharmacological and non-pharmacological methods of neuroprotection have been investigated in experimental studies and in animal models, and, although some have shown effectiveness in protection of the central nervous system, for most, clinical research is lacking or did not show the expected results. This review summarizes the value and need for neuroprotection in the context of cardiothoracic surgery and examines the use and effectiveness of several agents and methods with an emphasis on clinical trials and clinically relevant neuroprotectants.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":"11 1","pages":"27-37"},"PeriodicalIF":0.0,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.11.2019.01","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37717467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Effects of flavonol quercetin on activity of lipid peroxide oxidation in experimental bacterial-immune periodontitis. 黄酮醇槲皮素对实验性细菌免疫性牙周炎脂质过氧化活性的影响。
Q2 Medicine Pub Date : 2019-03-01 DOI: 10.1556/1646.10.2018.48
Andrii Demkovych

The article presents the results of lipid peroxidation activity in blood serum, which were assessed on the base changes in the level of oxidative modification of proteins, TBA-active products, and total amount of nitrogen (II) oxide metabolites (NO2 - + NO3 -). Indices were determined on the 14th day of development in experimental periodontitis both without correction, and in condition treatment with a water-soluble flavonol quercetin (corvitin). The treated animals take intramuscular injections of corvitin in a dose 100 mg/kg weight for 7 days. For further testing, blood serum was selected. The results were statistically analyzed using parametric and non-parametric indices. In this investigation, characterized dynamics of changes in the indices of oxidative processes activity were revealed both during the period of formation and the course of periodontitis. In particular, it was found that, for the period of the most expressed inflammatory reaction in the periodontal complex, intensive increase in the level of reactive forms of oxygen. The treatment with flavonol quercetin for 7 days resulted in stabilization of free radical processes and the suppression of the inflammatory reaction.

本文介绍了血清脂质过氧化活性的结果,该结果是根据蛋白质氧化修饰水平、tba活性产物水平和氮(II)氧化物代谢产物(NO2 - + NO3 -)总量的变化来评估的。在实验性牙周炎发生第14天测定各项指标,包括未进行矫正和用水溶性黄酮醇槲皮素治疗。治疗组动物肌肉注射柯维素,剂量为100 mg/kg体重,连续7天。选取血清作进一步检测。采用参数和非参数指标对结果进行统计分析。本研究揭示了在牙周炎形成期间和牙周炎病程中氧化过程活性指标变化的特征动态。特别是,研究发现,在牙周复合体炎症反应最强烈的时期,活性氧的水平急剧增加。黄酮醇槲皮素处理7天,自由基过程稳定,炎症反应抑制。
{"title":"Effects of flavonol quercetin on activity of lipid peroxide oxidation in experimental bacterial-immune periodontitis.","authors":"Andrii Demkovych","doi":"10.1556/1646.10.2018.48","DOIUrl":"https://doi.org/10.1556/1646.10.2018.48","url":null,"abstract":"<p><p>The article presents the results of lipid peroxidation activity in blood serum, which were assessed on the base changes in the level of oxidative modification of proteins, TBA-active products, and total amount of nitrogen (II) oxide metabolites (NO<sub>2</sub> <sup>-</sup> + NO<sub>3</sub> <sup>-</sup>). Indices were determined on the 14<sup>th</sup> day of development in experimental periodontitis both without correction, and in condition treatment with a water-soluble flavonol quercetin (corvitin). The treated animals take intramuscular injections of corvitin in a dose 100 mg/kg weight for 7 days. For further testing, blood serum was selected. The results were statistically analyzed using parametric and non-parametric indices. In this investigation, characterized dynamics of changes in the indices of oxidative processes activity were revealed both during the period of formation and the course of periodontitis. In particular, it was found that, for the period of the most expressed inflammatory reaction in the periodontal complex, intensive increase in the level of reactive forms of oxygen. The treatment with flavonol quercetin for 7 days resulted in stabilization of free radical processes and the suppression of the inflammatory reaction.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":"11 1","pages":"55-59"},"PeriodicalIF":0.0,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.10.2018.48","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37718335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
期刊
Interventional Medicine and Applied Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1